Tevogen Bio Holdings Inc. (TVGN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.73M | -2.18M | -3.65M | -3.19M | -3.31M | -3.05M | -3.8M | -2.98M | -2.16M | -1.98M | -1.8M | -2.22M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 17.36% | 28.43% | 4.08% | -6.95% | -52.88% | -54.2% | -111.37% | -34.5% | 0.61% | 27.78% | 10.32% | -4731.3% |
| Net Income | -5.45M | -4.68M | -5.73M | -5.5M | -10.37M | -9.25M | -5.88M | -9.66M | 11.26M | -3.63M | -3.9M | -22.18M |
| Depreciation & Amortization | 59.05K | -178.41K | 291.42K | 26.59K | 105.4K | 103.55K | 218.93K | -17.2K | 98.3K | 100.87K | 93.58K | 92.7K |
| Stock-Based Compensation | 2.85M | 2.45M | 3.24M | 3.24M | 7.29M | 0 | 3.33M | 4.14M | 26.33M | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -25.83K | 260.9K | -329.15K | 261.02K | 10.72K | 6.85M | -318.49K | 1.18M | -40.38M | 1.62M | 1.58M | 20M |
| Working Capital Changes | -170.33K | -32.09K | -1.13M | -1.21M | -349.82K | -749.04K | -1.15M | 1.37M | 517.84K | -68.11K | 431.38K | -125.87K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 458.47K | 28.2K | -1.03M | -424.44K | -535.5K | 0 | -827.87K | 1.45M | 1.7M | 141.37K | 306.12K | -124.87K |
| Cash from Investing | 0 | -64.44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | -64.44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 2.87M | 1.76M | 4M | 1.9M | 4M | 2M | 5M | 2.8M | 2.43M | 422.25K | 950K | 0 |
| Debt Issued (Net) | 2M | 0 | 0 | 1.4M | 2M | 0 | 1M | 0 | 0 | 350K | 1.15M | 0 |
| Equity Issued (Net) | 873.7K | 1.76M | 3M | 0 | 2M | 2M | 4M | 2.8M | 2.2M | 72.25K | -200K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 1M | 500K | 0 | 0 | 0 | 0 | 229.33K | 0 | 0 | 0 |
| Net Change in Cash | 139.93K | -484.72K | 351.87K | -1.29M | 691.94K | -1.05M | 1.2M | -182.51K | 265.5K | 704.85K | -208.46K | 503.73K |
| Free Cash Flow | -2.73M | -2.25M | -3.65M | -3.19M | -3.31M | -3.05M | -3.8M | -2.98M | -2.16M | -1.98M | -1.8M | -2.22M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 17.36% | 26.31% | 4.08% | -6.95% | -52.88% | -54.2% | -111.37% | -34.5% | 6.33% | 31.9% | 15.64% | -4731.2% |
| FCF per Share | -0.78 | -0.68 | -0.93 | -0.87 | -1.02 | -0.86 | -1.12 | -0.97 | -0.76 | -0.61 | -0.57 | -0.80 |
| FCF Conversion (FCF/Net Income) | 0.50x | 0.47x | 0.64x | 0.58x | 0.32x | 0.33x | 0.64x | 0.49x | -0.19x | 0.54x | 0.46x | 0.10x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |